|
DNA Mismatch repair and cancer in murine models
|
5R01CA076329-21
|
$380,585
|
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
|
5R01CA166429-06
|
$384,342
|
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
An Exploration of the Determinants that Impact Breast and Cervical Cancer Control
|
1R03CA132550-01
|
$50,000
|
$25,000
|
English, Kevin
|
ALBUQUERQUE AREA INDIAN HEALTH BOARD
|
|
Oncogenic microRNAs in HPV-infected cervical samples
|
5R43CA116218-02
|
$138,890
|
$138,890
|
Beaudenon, Sylvie
|
AMBION DIAGNOSTICS, INC.
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S1
|
$300,000
|
$3,000
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
5U10CA021661-32
|
$8,875,198
|
$88,752
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-20
|
$1,483,085
|
$118,647
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
5U24CA114734-03
|
$793,043
|
$79,304
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
5U24CA180803-04
|
$8,214,381
|
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group-Statistical Center
|
5U10CA032115-26
|
$1,038,338
|
$10,383
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-09
|
$778,031
|
$155,606
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
A Novel Diagnostic Assay for Oncogenic Human Papillomaviruses
|
5R44CA121155-03
|
$397,454
|
$397,454
|
LU, PETER
|
ARBOR VITA CORPORATION
|
|
Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Mo
|
R01AI122932-03
|
$20,693
|
|
Hu, Ye
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Identification of clonal DNA methylation and chromatin accessibility
|
1R03CA212829-01
|
$76,000
|
|
CHOI, JEONG-HYEON
|
AUGUSTA UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-14
|
$307,800
|
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
|
5R01CA168912-04
|
$320,588
|
|
HE, YUKAI
|
AUGUSTA UNIVERSITY
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$33,600
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Automated, Augmented Reality High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
3R01CA181275-03S1
|
$497,433
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer
|
5F30CA196108-03
|
$38,455
|
|
BADER, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer
|
1R03CA212816-01
|
$79,250
|
|
KAIPPARETTU, BENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel therapeutics for targeting checkpoint dysfunction in cancer
|
1R01CA203824-01A1
|
$362,569
|
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
MiRNAs in hepatocellular carcinoma development and treatment
|
2R01CA139158-06A1
|
$410,875
|
|
HUANG, WENDONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Regulation of Single Strand Annealing Repair of Mammalian Chromosomal Breaks
|
5R01CA197506-02
|
$388,875
|
|
STARK, JEREMY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Hyperglycemia-induced DNA damage as a driver of genomic instability
|
5R01CA176611-05
|
$393,639
|
|
TERMINI, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells
|
1K08CA201591-01A1
|
$169,560
|
|
WANG, LEO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$5,600
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$27,370
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Control of tumor growth and metastasis by the cytokine TSLP
|
5R01CA182783-04
|
$362,503
|
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Overcoming resistance to tyrosine kinase inhibitors in lung cancer
|
5R01CA169259-05
|
$1
|
|
KOBAYASHI, SUSUMU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of selective Pin1 inhibitors to target a common oncogenic mechanism
|
1R01CA205153-01A1
|
$673,119
|
|
LU, KUN PING
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-13
|
$328,700
|
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
p190 RhoGAP signaling in epithelial oncogenesis
|
1R01CA205158-01A1
|
$404,888
|
|
HANSEN, STEEN
|
BOSTON CHILDREN'S HOSPITAL
|
|
Single-molecule mechanical detection of protein and microRNA cancer biomarkers
|
1R21CA212827-01
|
$267,258
|
|
WONG, WESLEY
|
BOSTON CHILDREN'S HOSPITAL
|
|
Nuclear Import Pathways for HPV Macromolecules
|
2R01CA094898-05A1
|
$264,537
|
$264,537
|
MOROIANU, JUNONA
|
BOSTON COLLEGE
|
|
"Patient Navigation in the SafetyNet: CONNECTeDD"
|
5U01CA116892-03
|
$606,005
|
$151,501
|
FREUND, KAREN
|
BOSTON MEDICAL CENTER
|
|
Modeling bi-directional signaling and cytoskeletal dynamics in 3D cell migrations
|
5U01CA177799-05
|
$571,427
|
|
ZAMAN, MUHAMMAD
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas
|
5R01CA166172-05
|
$368,313
|
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
How does malignancy subvert platelet and megakaryocytic biology?
|
1R01CA200748-01A1
|
$550,945
|
|
ITALIANO, JOSEPH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biological Activity of HPV E7 in Human Epithelial Cells
|
5R01CA066980-12
|
$373,348
|
$373,348
|
Munger, Karl
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Modulation of Host Cell Apoptotic Responses by HPVE7
|
5R01CA081135-09
|
$282,084
|
$282,084
|
Munger, Karl
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
|
1R01CA203636-01A1
|
$606,587
|
|
NISHINO, MIZUKI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Delineating the mechanisms of androgen receptor activation function-1 antagonists for development of novel prostate cancer therapeutics
|
2R01CA105304-11A1
|
$260,847
|
|
SADAR, MARIANNE
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Understanding Reversed Race/Ethnic Associations with Cancer Screening Tests
|
1R21CA127828-01
|
$168,472
|
$42,118
|
RAKOWSKI, WILLIAM
|
BROWN UNIVERSITY
|
|
Metalloproteinases in Tumor Progression and Metastasis
|
5R01CA108959-03
|
$496,579
|
$124,145
|
SMITH, JEFFREY
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-27
|
$3,387,817
|
$33,878
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
2U10CA037429-22
|
$14,335,283
|
$1,003,470
|
Coltman, Charles
|
CANCER THERAPY AND RESEARCH CENTER
|
|
Carle Cancer Center Community Clinical Oncology Program
|
3U10CA035195-24S1
|
$120,000
|
$9,600
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-24
|
$693,116
|
$55,449
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
E2-Cellular Complexes in HPV Chromatin Transcription
|
5R01CA103867-04
|
$57,697
|
$57,697
|
CHIANG, CHENG-MING
|
CASE WESTERN RESERVE UNIVERSITY
|
|
EPHA6 as a novel candidate driver gene in colon cancer
|
5R01CA204549-02
|
$362,569
|
|
GUDA, KISHORE
|
CASE WESTERN RESERVE UNIVERSITY
|
Total relevant funding to Cervical Cancer for this search: $86,063,922
|